Annual report pursuant to Section 13 and 15(d)

BUSINESS SEGMENT AND GEOGRAPHIC REPORTING (Details Narrative)

v3.19.2
BUSINESS SEGMENT AND GEOGRAPHIC REPORTING (Details Narrative) - USD ($)
12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Business Segment And Geographic Reporting    
Total revenues, net $ 707,062 $ 197,554
Revenue percentage description The Company derives its revenues from services and products within the cannabinoid therapeutics / biopharmaceuticals CBD industry with no one external customer accounting for more than 10% of its revenue.